December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Danaher Corp (NY:DHR)

195.08 -1.09 (-0.56%)
Streaming Delayed Price Updated: 10:04 AM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Danaher Corp

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
29 30 Next >
News headline image
Earnings Scheduled For January 29, 2025 ↗
 
Via Benzinga
News headline image
Danaher Unusual Options Activity ↗
 
Via Benzinga
News headline image
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Jim Cramer Recommends Buying 'Fabulous' BlackRock, Calls Coterra Energy The 'Cheapest' Natural Gas Company ↗
Cramer comments on Danaher, Coterra, BlackRock and Digital Realty. As for Grail, "Just great science, but it is parabolic," he adds. 
Via Benzinga
Topics Energy
News headline image
3 Insanely Cheap Stocks to Buy ↗
The object is to buy low and sell high. 
Via The Motley Fool
News headline image
Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending Key To Recovery ↗
Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved investor sentiment likely. 
Via Benzinga
News headline image
Aldevron Unveils Next-Generation Alchemy™ Cell-Free DNA Technology for Research Grade Applications
From Aldevron
Via Business Wire
News headline image
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today ↗
 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning Danaher Stock In The Last 10 Years ↗
 
Via Benzinga
News headline image
14 Analysts Have This To Say About Danaher ↗
 
Via Benzinga
News headline image
5 High-Flying Stocks In Dan Loeb's Portfolio: Cinemark, Corpay, Amazon Lead ↗
Dan S. Loeb, founder of Third Point, a $7B hedge fund, is known for bold activist strategies that drive transformation in global companies. 
Via Benzinga
News headline image
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗
The Benzinga Stock Whisper Index highlights five stocks seeing increased interest from readers during the week and the reasons why the stocks may be drawing attention. 
Via Benzinga
News headline image
Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst ↗
BofA upgrades Danaher and Revvity, predicting a mixed but improving outlook for life sciences tools in fiscal year 2025 amid ongoing market challenges. 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
What the Options Market Tells Us About Danaher ↗
 
Via Benzinga
News headline image
What the Options Market Tells Us About Danaher ↗
 
Via Benzinga
News headline image
Peering Into Danaher's Recent Short Interest ↗
 
Via Benzinga
News headline image
Inquiry Into Danaher's Competitor Dynamics In Life Sciences Tools &amp; Services Industry ↗
 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
A Look Into Danaher Inc's Price Over Earnings ↗
 
Via Benzinga
News headline image
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $4,600 Today ↗
 
Via Benzinga
News headline image
Want to Grow a Passive Income Snowball? Buy These 7 Elite Dividend Growth Stocks. ↗
These seven companies are transforming steady profits into rising passive income streams for investors. 
Via The Motley Fool
News headline image
Critical Insights From Danaher Analyst Ratings: What You Need To Know ↗
 
Via Benzinga
News headline image
Danaher's Q3 Earnings Boosted By Bioprocessing Order Growth, Analyst Maintain Stock Rating ↗
Danaher posts Q3 sales of $5.79 billion, surpassing expectations. 2024 guidance includes bioprocessing revenue decline and Cepheid respiratory sales of $1.7 billion. 
Via Benzinga
News headline image
A Closer Look at Danaher's Options Market Dynamics ↗
 
Via Benzinga
News headline image
Earnings Preview: Danaher ↗
 
Via Benzinga
News headline image
This Is What Whales Are Betting On Danaher ↗
 
Via Benzinga
News headline image
Stocks Fall, GM Eyes Best Day In A Year, Gold Breaks Records, Silver Hits 12-Year Highs: What's Driving Markets Tuesday? ↗
Wall Street traded lower for the second consecutive day on Tuesday, as investor sentiment turned cautious with the U.S. presidential election just two weeks away. Concerns over U.S. fiscal policies and... 
Via Benzinga
News headline image
Life Science Giant Danaher Q3 Earnings: Revenue And EPS Beat, Sticks To Annual Guidance ↗
Danaher posted third-quarter sales of $5.8 billion, surpassing expectations, with growth in life sciences and diagnostics segments, and a 27.5% operating margin. 
Via Benzinga
News headline image
Hedge Fund Billionaire Daniel Loeb Bets On Trump Win, Singles Out This Recent Buy As Having 'Significant Upside Potential' ↗
Hedge fund manager Daniel Loeb is optimistic about the economy and market and he sees Trump likely retaking White House. 
Via Benzinga
Topics Economy Government
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.